{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T09:24:16Z","timestamp":1774603456779,"version":"3.50.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejphar.2024.177087","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T17:10:10Z","timestamp":1730567410000},"page":"177087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Are we better together? Addressing a combined treatment of pitavastatin and temozolomide for brain cancer"],"prefix":"10.1016","volume":"985","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3212-7324","authenticated-orcid":false,"given":"Jo\u00e3o","family":"Basso","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5764-0023","authenticated-orcid":false,"given":"Ana Miguel","family":"Matos","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5948-508X","authenticated-orcid":false,"given":"Saeid","family":"Ghavami","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6981-6639","authenticated-orcid":false,"given":"Ana","family":"Fortuna","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3636-5805","authenticated-orcid":false,"given":"Rui","family":"Vitorino","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3424-548X","authenticated-orcid":false,"given":"Carla","family":"Vitorino","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177087_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.semcancer.2020.08.002","article-title":"Effects of statins on brain tumors: a review","author":"Afshari","year":"2021","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejphar.2024.177087_bib2","first-page":"985","article-title":"The effects of statin therapy on brain tumors, particularly glioma: a review","volume":"34","author":"Alrosan","year":"2023","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.ejphar.2024.177087_bib3","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/sj.bjc.6603766","article-title":"The role of versican isoforms V0\/V1 in glioma migration mediated by transforming growth factor-\u03b22","volume":"96","author":"Arslan","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2024.177087_bib4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2018.04.039","article-title":"Repurposing drugs for glioblastoma: from bench to bedside","volume":"428","author":"Basso","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejphar.2024.177087_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-0716-1052-7_12","article-title":"Establishing orthotopic xenograft glioblastoma models for use in preclinical development","author":"Basso","year":"2021","journal-title":"Nanotherapy for Brain Tumor Drug Delivery"},{"key":"10.1016\/j.ejphar.2024.177087_bib6","first-page":"2553","article-title":"The anti-angiogenic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel: in 3D in vitro model","volume":"19","author":"Bayat","year":"2018","journal-title":"Asian Pac. J. Cancer Prev. APJCP: Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.ejphar.2024.177087_bib7","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1158\/0008-5472.CAN-16-1693","article-title":"Wnt5a drives an invasive phenotype in human glioblastoma stem-like cells","volume":"77","author":"Binda","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177087_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s00280-022-04424-4","article-title":"Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors","volume":"89","author":"B\u00fcsker","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177087_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112261","article-title":"Multifunctional silica-coated mixed polymeric micelles for integrin-targeted therapy of pediatric patient-derived glioblastoma","volume":"128","author":"Chauhan","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejphar.2024.177087_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay methodsynergy quantification method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177087_bib11","doi-asserted-by":"crossref","first-page":"vdac166","DOI":"10.1093\/noajnl\/vdac166","article-title":"Single-cell image analysis reveals over-expression of organic anion transporting polypeptides (OATPs) in human glioblastoma tissue","volume":"4","author":"Cooper","year":"2022","journal-title":"Neuro-Oncology Advances"},{"key":"10.1016\/j.ejphar.2024.177087_bib12","first-page":"1","article-title":"Mechanism of interaction between autophagy and apoptosis in cancer","author":"Das","year":"2021","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejphar.2024.177087_bib13","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3390\/cells9112339","article-title":"Simvastatin induces unfolded protein response and enhances temozolomide-induced cell death in glioblastoma cells","volume":"9","author":"Dastghaib","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.177087_bib14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4161\/bioa.20975","article-title":"The actin cytoskeleton as a sensor and mediator of apoptosis","volume":"2","author":"Desouza","year":"2012","journal-title":"BioArchitecture"},{"key":"10.1016\/j.ejphar.2024.177087_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/abbs\/gmw117","article-title":"Lipoprotein lipase and phospholipid transfer protein overexpression in human glioma cells and their effect on cell growth, apoptosis, and migration","volume":"49","author":"Dong","year":"2017","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.ejphar.2024.177087_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1186\/s12885-023-11043-6","article-title":"Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map","volume":"23","author":"Fu","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2024.177087_bib17","first-page":"382","article-title":"Metabolic stability and uptake by human hepatocytes of pitavastatin, a new inhibitor of HMG-CoA reductase","volume":"54","author":"Fujino","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.ejphar.2024.177087_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10014-013-0139-z","article-title":"Immunohistochemical actinin-4 expression in infiltrating gliomas: association with WHO grade and differentiation","volume":"31","author":"Fukushima","year":"2014","journal-title":"Brain Tumor Pathol."},{"key":"10.1016\/j.ejphar.2024.177087_bib19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-021-00855-2","article-title":"EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma","volume":"7","author":"Gai","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2024.177087_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-015-1473-9","article-title":"Quantitative proteomic analysis shows differentially expressed HSPB1 in glioblastoma as a discriminating short from long survival factor and NOVA1 as a differentiation factor between low-grade astrocytoma and oligodendroglioma","volume":"15","author":"Gimenez","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2024.177087_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/9599608","article-title":"Implications on the therapeutic potential of statins via modulation of autophagy","volume":"2021","author":"Gorabi","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2024.177087_bib22","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fonc.2018.00394","article-title":"Mevalonate metabolism in cancer stemness and trained immunity","volume":"8","author":"Gruenbacher","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2024.177087_bib23","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1159\/000493293","article-title":"Enhanced expression of TGFBI promotes the proliferation and migration of glioma cells","volume":"49","author":"Guo","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejphar.2024.177087_bib24","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/21541248.2016.1232583","article-title":"Rho GTPases: regulation and roles in cancer cell biology","volume":"7","author":"Haga","year":"2016","journal-title":"Small GTPases"},{"key":"10.1016\/j.ejphar.2024.177087_bib25","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3390\/biology12020302","article-title":"Temozolomide, simvastatin and acetylshikonin combination induces mitochondrial-dependent apoptosis in GBM cells, which is regulated by autophagy","volume":"12","author":"Hajiahmadi","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.ejphar.2024.177087_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-01853-8","article-title":"Challenges of applying multicellular tumor spheroids in preclinical phase","volume":"21","author":"Han","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2024.177087_bib27","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317706455","article-title":"Knockdown of calponin 2 suppressed cell growth in gastric cancer cells","volume":"39","author":"Hu","year":"2017","journal-title":"Tumor Biol."},{"key":"10.1016\/j.ejphar.2024.177087_bib28","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/bjc.2014.431","article-title":"In vitro and in vivo anticancer effects of mevalonate pathway modulation on human cancer cells","volume":"111","author":"Jiang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejphar.2024.177087_bib29","first-page":"1","article-title":"Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs","volume":"12","author":"Jiang","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejphar.2024.177087_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02041-2","article-title":"Statins: a repurposed drug to fight cancer","volume":"40","author":"Jiang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177087_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.7150\/ijms.21113","article-title":"Lentivirus-mediated shRNA targeting CNN2 inhibits hepatocarcinoma in vitro and in vivo","volume":"15","author":"Kang","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ejphar.2024.177087_bib32","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/sj.cdd.4401359","article-title":"Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells","volume":"11","author":"Kanzawa","year":"2004","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2024.177087_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01151-4","article-title":"Perspective of mesenchymal transformation in glioblastoma","volume":"9","author":"Kim","year":"2021","journal-title":"Acta neuropathologica communications"},{"key":"10.1016\/j.ejphar.2024.177087_bib34","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.3390\/ijms22084150","article-title":"Temozolomide induces the acquisition of invasive phenotype by o6-methylguanine-dna methyltransferase (Mgmt)+ glioblastoma cells in a snail-1\/cx43-dependent manner","volume":"22","author":"Kochanowski","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177087_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.cmet.2018.07.010","article-title":"Interplay between YAP\/TAZ and metabolism","volume":"28","author":"Koo","year":"2018","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2024.177087_bib36","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1200\/OP.22.00476","article-title":"Key clinical principles in the management of glioblastoma","volume":"19","author":"Kotecha","year":"2023","journal-title":"JCO oncology practice"},{"key":"10.1016\/j.ejphar.2024.177087_bib37","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1111\/jcmm.15389","article-title":"Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a","volume":"24","author":"Lee","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2024.177087_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-018-0861-9","article-title":"KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc","volume":"37","author":"Li","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177087_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejphar.2024.177087_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.638397","article-title":"SETMAR shorter isoform: a new prognostic factor in glioblastoma","volume":"11","author":"Li\u00e9","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejphar.2024.177087_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cca.2007.07.022","article-title":"Determination of pitavastatin in human plasma via HPLC-ESI-MS\/MS and subsequent application to a clinical study in healthy Chinese volunteers","volume":"386","author":"Lv","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejphar.2024.177087_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1006832","article-title":"Parvifloron D-based potential therapy for glioblastoma: inducing apoptosis via the mitochondria dependent pathway","volume":"13","author":"Magalh\u00e3es","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177087_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrm3735","article-title":"Self-consumption: the interplay of autophagy and apoptosis","volume":"15","author":"Marino","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2024.177087_bib44","first-page":"214","article-title":"Bcl-2: beclin 1 complex: multiple, mechanisms regulating autophagy\/apoptosis toggle switch","volume":"2","author":"Marquez","year":"2012","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177087_bib45","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ijpharm.2017.07.056","article-title":"Breaching barriers in glioblastoma. Part I: molecular pathways and novel treatment approaches","volume":"531","author":"Miranda","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejphar.2024.177087_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ncrna9010004","article-title":"Deciphering the role of microRNA mediated regulation of coronin 1C in glioblastoma development and metastasis","volume":"9","author":"Mustafov","year":"2023","journal-title":"Non-Coding RNA"},{"key":"10.1016\/j.ejphar.2024.177087_bib47","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/noac202","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2015\u20132019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejphar.2024.177087_bib48","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12859-023-05425-7","article-title":"Molecular complex detection in protein interaction networks through reinforcement learning","volume":"24","author":"Palukuri","year":"2023","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.ejphar.2024.177087_bib49","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41590-023-01605-y","article-title":"Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma","volume":"24","author":"Pang","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ejphar.2024.177087_bib50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41418-017-0026-y","article-title":"The interplay between mutant p53 and the mevalonate pathway","volume":"25","author":"Parrales","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2024.177087_bib51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.bbrc.2017.05.147","article-title":"Atorvastatin augments temozolomide's efficacy in glioblastoma via prenylation-dependent inhibition of Ras signaling","volume":"489","author":"Peng","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2024.177087_bib52","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.3390\/cancers14143500","article-title":"Mutant p53, the mevalonate pathway and the tumor microenvironment regulate tumor response to statin therapy","volume":"14","author":"Pereira","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2024.177087_bib53","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1158\/1078-0432.CCR-09-1349","article-title":"The neuropharmacokinetics of temozolomide in patients with resectable brain tumors: potential implications for the current approach to chemoradiation","volume":"15","author":"Portnow","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177087_bib54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.wneu.2017.04.053","article-title":"Recurrence pattern analysis of primary glioblastoma","volume":"103","author":"Rapp","year":"2017","journal-title":"World neurosurgery"},{"key":"10.1016\/j.ejphar.2024.177087_bib55","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.3390\/cancers15205112","article-title":"Comparative analysis of the gnai family genes in glioblastoma through transcriptomics and single-cell technologies","volume":"15","author":"Raza","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2024.177087_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40265-021-01668-x","article-title":"Statins and gliomas: a systematic review of the preclinical studies and meta-analysis of the clinical literature","volume":"82","author":"Rendon","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2024.177087_bib57","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.2147\/OTT.S249985","article-title":"Rapamycin reduces cervical cancer cells viability in hypoxic condition: investigation of the role of autophagy and apoptosis","author":"Rezazadeh","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2024.177087_bib58","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3390\/antibiotics11020280","article-title":"Statins induce actin cytoskeleton disassembly and an apoptosis-like process in acanthamoeba spp","volume":"11","author":"Rodr\u00edguez-Exp\u00f3sito","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejphar.2024.177087_bib59","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3892\/ijo.2012.1570","article-title":"Role of metallothionein 1E in the migration and invasion of human glioma cell lines","volume":"41","author":"Ryu","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.ejphar.2024.177087_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101127","article-title":"A comprehensive review on the lipid and pleiotropic effects of pitavastatin","volume":"84","author":"Sahebkar","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejphar.2024.177087_bib61","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3390\/cancers11111651","article-title":"Identification of SERPINE1 as a regulator of glioblastoma cell dispersal with transcriptome profiling","volume":"11","author":"Seker","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ejphar.2024.177087_bib62","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/neuonc\/nou218","article-title":"Differential regulation of TGF-\u03b2\u2013induced, ALK-5\u2013mediated VEGF release by SMAD2\/3 versus SMAD1\/5\/8 signaling in glioblastoma","volume":"17","author":"Seystahl","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejphar.2024.177087_bib63","doi-asserted-by":"crossref","first-page":"533.541","DOI":"10.1096\/fasebj.2018.32.1_supplement.533.41","article-title":"Inhibition of autophagy by mevalonate pathway inhibitors, a new therapeutic approach to sensitize glioblastoma cells to temozolomide induced apoptosis","volume":"32","author":"Shojaei","year":"2018","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2024.177087_bib64","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nrclinonc.2017.122","article-title":"Glioblastoma subtypes revisited","volume":"14","author":"Sidaway","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2024.177087_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-8-223","article-title":"Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration","volume":"8","author":"Sodek","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejphar.2024.177087_bib66","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.3390\/ijms22094964","article-title":"Mesenchymal and proneural subtypes of glioblastoma disclose branching based on gsc associated signature","volume":"22","author":"Steponaitis","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177087_bib67","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2024.177087_bib68","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2024.177087_bib69","doi-asserted-by":"crossref","first-page":"W556","DOI":"10.1093\/nar\/gkz430","article-title":"GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis","volume":"47","author":"Tang","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2024.177087_bib70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2024.177087_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7007-10-29","article-title":"Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation","volume":"10","author":"Vinci","year":"2012","journal-title":"BMC Biol."},{"key":"10.1016\/j.ejphar.2024.177087_bib72","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3390\/ijms21061932","article-title":"Tumor cell invasion in glioblastoma","volume":"21","author":"Vollmann-Zwerenz","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177087_bib73","doi-asserted-by":"crossref","first-page":"942","DOI":"10.7150\/ijbs.65653","article-title":"RhoJ facilitates angiogenesis in glioblastoma via JNK\/VEGFR2 mediated activation of PAK and ERK signaling pathways","volume":"18","author":"Wang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2024.177087_bib74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2024.177087_bib75","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1158\/0008-5472.CAN-17-0114","article-title":"MYC-regulated mevalonate metabolism maintains brain tumor\u2013initiating cells","volume":"77","author":"Wang","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177087_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.756606","article-title":"The ALDH family contributes to immunocyte infiltration, proliferation and epithelial-mesenchymal transformation in glioma","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2024.177087_bib77","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/hc0602.103393","article-title":"Statins have biphasic effects on angiogenesis","volume":"105","author":"Weis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2024.177087_bib78","doi-asserted-by":"crossref","DOI":"10.1002\/rcm.9670","article-title":"Liquid chromatography\u2013mass spectrometry\u2010based metabolomics and fluxomics reveals the metabolic alterations in glioma U87MG multicellular tumor spheroids versus two\u2010dimensional cell cultures","volume":"38","author":"Wen","year":"2024","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.ejphar.2024.177087_bib79","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.18632\/oncotarget.26733","article-title":"Statins affect human glioblastoma and other cancers through TGF-\u03b2 inhibition","volume":"10","author":"Xiao","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2024.177087_bib80","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2024.177087_bib81","first-page":"5383","article-title":"Pitavastatin suppressed liver cancer cells in vitro and in vivo","author":"You","year":"2016","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2024.177087_bib82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejphar.2024.177087_bib83","article-title":"Statins and angiogenesis in non-cardiovascular diseases","volume":"27","author":"Zahedipour","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejphar.2024.177087_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172665","article-title":"DHFR\/TYMS are positive regulators of glioma cell growth and modulate chemo-sensitivity to temozolomide","volume":"863","author":"Zhao","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2024.177087_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.716730","article-title":"Ribosome proteins represented by RPL27A mark the development and metastasis of triple-negative breast cancer in mouse and human","volume":"9","author":"Zhao","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2024.177087_bib86","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14605","article-title":"HTRA1 promotes EMT through the HDAC6\/Ac\u2010\u03b1\u2010tubulin pathway in human GBM cells","volume":"30","author":"Zhao","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2024.177087_bib87","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2710693","article-title":"Lovastatin enhances cytotoxicity of temozolomide via impairing autophagic flux in glioblastoma cells","volume":"2019","author":"Zhu","year":"2019","journal-title":"BioMed Res. Int."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T01:28:49Z","timestamp":1733621329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924007775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":87,"alternative-id":["S0014299924007775"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177087","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are we better together? Addressing a combined treatment of pitavastatin and temozolomide for brain cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177087"}}